EuroSafe Imaging Session - Jointly organised with the World Health Organization (WHO) and the International Society of Radiology (ISR)

EU 7 - CT lung cancer screening vs individual health assessment: examples and first experiences in Europe

Lectures

1
Chairperson's introduction

Chairperson's introduction

05:00Ferid Shannoun, Geneva / CH

2
Overview of WHO CT-IHA framework for good governance document

Overview of WHO CT-IHA framework for good governance document

20:00Steve Ebdon-Jackson, Reading / UK

3
Case study, CT-for lung cancer screening in Croatia: experience from the ongoing programme

Case study, CT-for lung cancer screening in Croatia: experience from the ongoing programme

15:00Maja Hrabak Paar, Zagreb / HR

4
Differences and similarities of population screening and IHA

Differences and similarities of population screening and IHA

15:00Mathias Prokop, Nijmegen / NL

5
Situation in Europe

Situation in Europe

15:00Eva Godske Friberg, Oesteraas / NO

6
Discussion All speakers and

Discussion All speakers and

20:00Boris Brkljačić, Zagreb / HR

5 min
Chairperson's introduction
Ferid Shannoun, Geneva / Switzerland
20 min
Overview of WHO CT-IHA framework for good governance document
Steve Ebdon-Jackson, Reading / United Kingdom
  1. To learn the contents of the WHO CT-IHA framework document.
  2. To appreciate the range of aspects associated with CT-IHA.
  3. To understand the issues surrounding the introduction of CT-IHA into a healthcare system.
15 min
Case study, CT-for lung cancer screening in Croatia: experience from the ongoing programme
Maja Hrabak Paar, Zagreb / Croatia
  1. To describe the organisational concept of the ongoing lung cancer screening programme in Croatia.
  2. To learn management strategies for patients with positive screening results, as well as follow-up intervals based on LDCT findings.
  3. To show the first results of the lung cancer screening programme in Croatia.
15 min
Differences and similarities of population screening and IHA
Mathias Prokop, Nijmegen / Netherlands
  1. To learn about the potential benefits and risks for participants in IHA.
  2. To understand the societal costs of IHA.
  3. To appreciate which downstream management problems are caused by searching for incidental findings.
15 min
Situation in Europe
Eva Godske Friberg, Oesteraas / Norway
  1. To learn about the current legislative requirements and governance frameworks for CT examinations of asymptomatic individuals in Europe, including an overview of which CT-based screening programs and Individual Health Assessments (IHA) are performed today — recognizing that some practices are justified while others may not be, and highlighting changes in practice and regulation over the past decade since the implementation of the BSSD.
  2. To appreciate the diversity of national practices and initiatives, with a focus on possible measures such as awareness campaigns, regulatory actions, and other strategies aimed at reducing unjustified CT-IHA and addressing inappropriate or illegal advertising.
  3. To understand why a robust framework for good governance and regulatory activity is essential to improve justification of CT examinations for asymptomatic individuals, and to consider the ethical implications of preventive imaging in healthcare.
20 min
Discussion
All speakers and
Boris Brkljačić, Zagreb / Croatia